High-sensitivity C-reactive protein, adiposity, and blood pressure in the Yakut of Siberia

American Journal of Human Biology

Volumn 18, Issue 6, 2006, Pages 766-775

  Sorensen, M V ^a   Leonard, W R ^b   Tarskaya, L A ^c   Ivanov, K I ^d   Snodgrass, J J ^e   Alekseev, V P ^f   Krivoshapkin, V G ^f   Rifai, N ^g  

^a University of North Carolina at Chapel Hill   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^d N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^e UNIVERSITY OF OREGON   (United States)

^f RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPID;

ADULT; AGE DISTRIBUTION; AGRICULTURAL WORKER; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CULTURAL FACTOR; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INDIGENOUS PEOPLE; LIFESTYLE; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; RUSSIAN FEDERATION; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TURBIDIMETRY; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ANTHROPOMETRY; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SIBERIA;

EID: 33750868008     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.20547     Document Type: Article

References (59)

1. Aziz N, Fahey JL, Detels R, Butch AW. 2003. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol 10:652-657.
2. Bautista LE, Lopez-Jaramillo P, Vera LM, Casa JP, Otero AP, Guaracao AI. 2001. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19:857-861.
3. Bautista LE, Vera LM, Arenas IA, Gamarra G. 2005. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 19:149-154.
4. Blake GJ, Rifai N, Buring JE, Ridker PM. 2003. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 108:2993-2999.
5. Centers for Disease Control and Prevention. 2004. Cigarette smoking among adulta - United States, 2002. MMWR 53: 427-431.
6. Chae CU, Lee RT, Rifai N, Ridker PM. 2001. Blood pressure and inflammation in apparently healthy men. Hypertension 38:399-403.
7. Chobanian AV, Alexander RW. 1996. Exacerbation of atherosclerosis by hypertension. Potential mechanism and clinical implications. Arch Intern Med 156:1952-1956.
8. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J [Clin Res] 321:199-204.
9. Durnin J, Womersley J. 1974. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97.
10. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. 2003. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799-1804.
11. Ford ES. 1999. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977.
12. Ford ES, Giles WH, Dietz WH. 2002. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359.
13. Forouhi NG, Sattar N, McKeigue PM. 2001. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25:1327-1331.
14. Gibson R. 2005. Principles of nutritional assessment. New York: Oxford.
15. Giltay EJ, Geleijnse JM, Schouten EG, Katan MB, Kromhout D. 2003. High stability of markers of cardiovascular risk in blood samples. Clin Chem 49:652-655.
16. Gotto AM, Pownall HJ. 1999. Manual of lipid disorders: reducing the risk for coronary heart disease. Baltimore: Lippincot Williams & Wilkins.
17. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438.
18. Han Y, Runge MS, Brasier AR. 1999. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84:695-703.
19. Hutchinson WL, Koenig W, Frohlich M, Sund M, Lowe GD, Pepys MB. 2000. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 46:934-938.
20. Imhof A, Frohlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, Lowe GD, Koenig W. 2003. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem 49:669-672.
21. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. 2004. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549-2557.
22. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys ME. 1999. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237-242.
23. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. 1999. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vase Biol 19:1623-1629.
24. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. 1999. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100:96-102.
25. Ledue TB, Rifai N. 2003. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 49:1258-1271.
26. Leonard WR. 2003. Measuring human energy expenditure: what have we learned from the flex-heart rate method? Am J Hum Biol 15:479-489.
27. Leonard WR, Crawford MH, Comuzzie AG, Sukernik RI. 1994. Correlates of low serum-lipid levels among the Evenki herders of Siberia. Am J Hum Biol 6:329-338.
28. Leonard WR, Galloway VA, Ivakine E, Osipova L, Kazakovtseva M. 2002. Ecology, health and lifestyle change among the Evenki herders of Siberia. In: Leonard WR, Crawford MH, editors. Human biology of pastoral populations. Cambridge: Cambridge University Press. p 206-235.
29. Leonard WR, Snodgrass JJ, Sorensen MV. 2005. Metabolic adaptation in indigenous Siberian populations. Annu Rev Anthropol 34:451-471.
30. Libby P, Ridker PM. 1999. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100:1148-1150.
31. McGarvey ST, Bindon JR, Crews DE, Schendel DE. 1989. Modernization and adiposity: causes and consequences. In: Little MA, Haas JD, editors. Human population biology: a transdisciplinary science. New York: Oxford University Press. p 263-279.
32. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47:426-430.
33. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. 1997. Subcutaneous adipose tissue releases interleuldn-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82:419-4200.
34. Mohamed-Ali V, Pinkney JH, Coppack SW. 1998. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145-1158.
35. Onat A, Sansoy V, Yildirim B, Keles I, Uysal O, Hergenc G. 2001. C-reactive protein and coronary heart disease in western Turkey. Am J Cardiol 88:601-607.
36. Pai JK, Curhan GC, Cannuscio CC, Rifei N, Ridker PM, Rimm EB. 2002. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 48:1781-1784.
37. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511.
38. Ridker PM. 2001. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813-1818.
39. Ridker PM, Glynn RJ, Hennekens CH. 1998. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007-2011.
40. Ridker PM, Hennekens CH, Buring JE, Rifai N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843.
41. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565.
42. Rifai N, Ridker PM. 2003. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 49:666-669.
43. Rifai N, Tracy RP, Ridker PM. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45:2136-2141.
44. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. 2000. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 46:461-468.
45. Ross R. 1999. Atherosclerosis - an inflammatory disease. N Eng] J Med 340:115-126.
46. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. 2003. C-reactive protein and the risk of developing hypertension. JAMA 290:2945-2951.
47. Shepherd RJ, Rode A. 1996. The health consequences of modernization: evidence from circumpolar peoples. Cambridge: Cambridge University Press.
48. Snodgrass JJ. 2004. Energetics, health, and economic modernization in the Yakut (Sakha) of Siberia: a biocultural perspective on lifestyle change in a circumpolar population. Evanston: Northwestern University.
49. Sorensen MV. 2003. Social and biological determinants of cardiovascular risk among rural and urban Yakut: the impact of socioeconomic upheaval. Ph.D. dissertation, Northwestern University.
50. Sorensen MV, Snodgrass JJ, Leonard WR, Tarskaia LA, Ivanov KI, Krivoshapkin VG, Spitsyn VA. 2005. Health consequences of postsocialist transition: dietary and lifestyle determinants of plasma lipids in Yakutia. Am J Hum Biol 17:576-592.
51. Tokarev SA. 1940. Ocherki Istorii Iakutskogo Naroda. Moskva: Gosudarstvennoye Sotsialno-Ekonomicheskoye Izdatelstvo.
52. Tokarev SA, Gurvich IS. 1956. The Yakuts. In Levin MG, Potapov LP, editors. Peoples of Siberia. Chicago: University of Chicago Press.
53. van Eijsden M, van der Wal MF, Hornstra G, Bonsel GJ. 2005. Can whole-blood samples be stored over 24 hours without compromising stability of C-reactive protein, retinol, ferritin, folic acid, and fatty acids in epidemiologic research? Clin Chem 51:230-232.
54. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA. 2002. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105:1890-1896.
55. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135.
56. Wilkins J, Gallimore JR, Moore EG, Pepys MB. 1998. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 44:1358-1361.
57. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kojii E. 2001. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 153:1183-1190.
58. You T, Berman DM, Ryan AS, Nicklas BJ. 2004. Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 89:1739-1746.
59. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. 1999. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and andothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vase Biol 19:972-978.